Navigation Links
ERT to Present at the 29th Annual J.P. Morgan Healthcare Conference on January 13, 2011
Date:1/4/2011

PHILADELPHIA, Jan. 4, 2011 /PRNewswire/ -- ERT (Nasdaq: ERES), announced today that Dr. Joel Morganroth, the Company's Chairman and CEO, and Keith Schneck, the Company's Chief Financial Officer, are scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference at 9:30 AM PST on January 13, 2011 in San Francisco, California.

Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com. The webcast may also be accessed at http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink?ticker=ERES.  The webcast will be available via replay for 90 days.

About ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (www.ert.com) is a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. It is also a leading provider of centralized respiratory technology and services to evaluate pulmonary function efficacy and safety in clinical development. Sponsors can further use the Company's solutions to streamline the clinical trials process by automating the collection, analysis, and distribution of ePRO clinical data using multi-mode technology in all phases of clinical development as well as selected medical devices for the clinical trials and healthcare industries.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endo to Present at the J.P. Morgan 29th Annual Healthcare Conference
2. Warner Chilcott to Present at the 29th Annual J.P. Morgan Healthcare Conference
3. NxStage to Present at the 29th Annual J.P. Morgan Healthcare Conference
4. ADVENTRX Pharmaceuticals to Present at the 4TH Annual OneMedForum Business Development and Investment Conference on January 11
5. Syndax Pharmaceuticals to Present at Biotech Showcase 2011
6. PAREXEL International to Present at J.P. Morgan Healthcare Conference
7. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
8. Medco CEO to Present at Upcoming Healthcare Conferences
9. Misonix to Present at Sidoti & Company 2011 Micro Cap Conference
10. Bacterin International Holdings to Present at the OneMedForum San Francisco 2011
11. Express Scripts to Present at the J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy ... nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch of ... moisturizer with the power of an anti-aging concentrate. , Anogeissus Leiocarpa ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... celebrating its 5th anniversary. SearchLight is the premier online modeling resource for fluorescence ... more than 30,000 active users during last 5 years spanning the globe, SearchLight ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis of ... field. Offering practical takeaways to apply immediately to IRR programs, the report highlights ...
(Date:4/27/2017)... Minneapolis, Minnesota (PRWEB) , ... April 27, 2017 ... ... Smith and her husband Dan Gasby the 2017 Public Leadership in Neurology Award ... Bob Woodruff, retired professional athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael ...
(Date:4/27/2017)... ... 27, 2017 , ... Goodcents Deli Fresh Subs announced a franchise expansion agreement ... year. , The first new location will open at the corner of 27th ... and Northern Lights Drive this fall. And the third location is in the process ...
Breaking Medicine News(10 mins):